Hot Topic Networking

Drug repositioning: Finding new uses for existing medicines
Wednesday, 21 September 2022
Register Here

Event overview:

Drug repositioning and repurposing aims to discover new indications for existing medicines. Novel technologies and tools are being adopted in favour of traditional methods to increase chances of success into a range of therapy areas. Learn about the technologies and partnerships within drug discovery that are advancing the field of indication discovery and expansion.

Agenda:

  • 12.00 Lunch & Networking
  • 13.00 Site Welcome – Cliff Dennett – Bruntwood Birmingham Health Innovation Campus
  • 13.05 Chair Welcome – Adrian Freeman – Senior Director Indication Expansion – Emerging
  • Innovations Unit, AstraZeneca
  • 13.10 Dr Kelly Grey – Associate Principal Scientist Open Innovation – Emerging Innovations Unit, AstraZeneca
  • 13.30 Prof Patricia Lalor – Professor of Experimental Hepatology  – University of Birmingham
  • 13.50 Prof Zubair Ahmed – Neuroscience and Ophthalmology Section Lead – Institute of Inflammation and Ageing
  • 14.10 Dr Toby Hurd – Principal Pharmacologist – Healx
  • 14.30 – Joint Discussion & Q&A
  • 15.00 Coffee & Networking
Register Here

Our App

ALL OUR EVENT INFORMATION IN
THE PALM OF YOUR HAND

If you plan to attend an ELRIG event download the free ELRIG app and access all our conference information and lecture schedules and more straight from your phone or pad..

Download Now
Menu